Approval · Notice of Compliance 9863 · 2008
COVERSYL PLUS: Notice of Compliance 9863
Issued October 28, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9863
- Date
- October 28, 2008
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin converting enzyme inhibitor / diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COVERSYL PLUS | 02318555 | Cancelled Pre Market |
| COVERSYL PLUS LD | 02318563 | Cancelled Pre Market |
Medicinal ingredients
- PERINDOPRIL ARGININE 5 MG per TAB
- INDAPAMIDE 1.25 MG per TAB
- PERINDOPRIL ARGININE 2.5 MG per TAB
- INDAPAMIDE 0.625 MG per TAB